Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2018-03-05 | 2018-03-20 | 41868 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2024-10-10 | 2024-11-08 | 239822 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2023-12-15 | 2023-12-22 | 213562 |
| APO-ENALAPRIL | 10MG | TABLET | Resolved | 2022-06-17 | 2022-06-30 | 162913 |
| APO-ENALAPRIL | 10MG | TABLET | Resolved | 2017-11-01 | 2018-01-03 | 27703 |
| APO-ENALAPRIL | 10MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37949 |
| APO-ENALAPRIL | 2.5MG | TABLET | Resolved | 2019-08-07 | 2019-12-19 | 91078 |
| APO-ENALAPRIL | 2.5MG | TABLET | Resolved | 2020-11-26 | 2021-03-09 | 128942 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2021-08-27 | 2022-07-11 | 144672 |
| APO-ENALAPRIL | 20MG | TABLET | Resolved | 2017-11-01 | 2018-04-07 | 27707 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2017-11-01 | 2017-12-20 | 27710 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2018-02-01 | 2018-04-07 | 37953 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2020-09-09 | 2021-03-09 | 123932 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2018-10-25 | 2018-12-08 | 65595 |
| APO-ENALAPRIL | 5MG | TABLET | Resolved | 2019-09-18 | 2019-12-19 | 94168 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192815 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2018-09-04 | 2019-05-13 | 59813 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
| APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2020-03-27 | 2020-07-06 | 109678 |
| APO-ERLOTINIB | 100MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74875 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |